Knowledge and understanding of pharmacogenomic testing among patients and health care professionals: A scoping review.

Health literacy Knowledge translation Pharmacogenetics Pharmacogenomic testing Scoping review

Journal

Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280

Informations de publication

Date de publication:
11 2019
Historique:
received: 08 09 2018
revised: 06 06 2019
accepted: 09 06 2019
pubmed: 24 6 2019
medline: 25 8 2020
entrez: 24 6 2019
Statut: ppublish

Résumé

To support the introduction of pharmacogenomic tests in current practice, this study identifies the factors associated with a better understanding of the information related to genetic, genomic and/or pharmacogenomic tests by patients and health care professionals. Following a scoping review methodology, a search for literature was conducted with keywords related to health literacy and knowledge translation in the context of pharmacogenomic tests. Since only 6 articles were identified, the context of genetic or genomic testing were added to the inclusion criteria, leading to 24 articles. Fourteen of the studies analyzed focused on genetic predictive, diagnostic or carrier tests, or concerned genetics in general, while ten addressed or included the use of pharmacogenomic tests. Demographic, individual, experiential and contextual factors were associated with a better understanding of the information related to genetic, genomic and/or pharmacogenomic tests among the targeted populations. Our review shows that there is currently little empirical research available to identify the factors to consider in order to develop educational tools and resources specific to pharmacogenomics. Expanding our review to include genetic and genomic testing factors can serve as a starting point for the evidence to be validated in future empirical research.

Identifiants

pubmed: 31229328
pii: S0738-3991(18)30712-2
doi: 10.1016/j.pec.2019.06.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Pagination

2001-2009

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Sophie Veilleux (S)

Department of Management, FSA ULaval - Business School, 2325, rue de la Terrasse, Pavillon Palasis-Prince, office 0533, Université Laval, Québec, Québec, G1V 0A6, Canada. Electronic address: Sophie.Veilleux@fsa.ulaval.ca.

Maud Bouffard (M)

FSA ULaval - Business School, 2325, rue de la Terrasse, Pavillon Palasis-Prince, Université Laval, Québec, Québec, G1V 0A6, Canada. Electronic address: maud.bouffard.1@ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH